We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$40.7B
AUM Growth
+$1.22B
(+3.1%)
Cap. Flow
+$984M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
29.3%
Holding
1,190
New
178
Increased
257
Reduced
455
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum China
YUMC
|
+$295M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$216M |
| 3 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$196M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$140M |
| 5 |
ARNC.PRB
Arconic Inc.
ARNC.PRB
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$128M |
| 2 |
AGN
Allergan plc
AGN
|
+$122M |
| 3 |
AA.PRB
Alcoa Inc
AA.PRB
|
+$71.7M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$62.4M |
| 5 |
GHL
Greenhill & Co., Inc.
GHL
|
+$61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Financials | 12.44% |
| 3 | Consumer Discretionary | 12.42% |
| 4 | Healthcare | 11.6% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Penumbra
PEN
$12.8B
| $3.29M | 0.01% |
+51,554
| New | +$3.45M |
|
|
MON
527
DELISTED
Monsanto Co
MON
| $3.16M | 0.01% |
30,000
-1,713
| -5% | -$176K |
|
528
Calix
CALX
$2.39B
| $3.12M | 0.01% |
405,497
-230,110
| -36% | -$1.68M |
|
|
NXRT
529
NexPoint Residential Trust
NXRT
$652M
| $3.07M | 0.01% |
137,569
-316,143
| -70% | -$6.21M |
|
|
KE
530
Kimball Electronics
KE
$628M
| $3.04M | 0.01% |
167,169
-947
| -0.6% | -$15.2K |
|
531
Neurocrine Biosciences
NBIX
$16.6B
| $2.74M | 0.01% |
70,808
-1,174
| -2% | -$53.1K |
|
|
BSL
532
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
| $2.71M | 0.01% |
149,810
+10,687
| +8% | +$187K |
|
533
Paylocity
PCTY
$7.98B
| $2.71M | 0.01% |
90,267
-49,189
| -35% | -$1.83M |
|
534
Morgan Stanley
MS
$340B
| $2.55M | 0.01% |
+60,300
| New | +$2.28M |
|
|
BRW
535
Saba Capital Income & Opportunities Fund
BRW
$339M
| $2.46M | 0.01% |
222,250
+53,500
| +32% | +$573K |
|
536
Baidu
BIDU
$37.2B
| $2.31M | 0.01% |
14,062
+217
| +2% | +$36.9K |
|
|
EFR
537
Eaton Vance Senior Floating-Rate Fund
EFR
$317M
| $2.1M | 0.01% |
142,410
+50,000
| +54% | +$716K |
|
|
SPLK
538
DELISTED
Splunk Inc
SPLK
| $2.05M | 0.01% |
+40,016
| New | +$2.3M |
|
|
CBB.PRB
539
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $1.9M | ﹤0.01% |
11,213
-44,851
| -80% | -$2.23M |
|
540
International Paper
IP
$22B
| $1.81M | ﹤0.01% |
36,043
+5,847
| +19% | +$270K |
|
541
Mercado Libre
MELI
$92.3B
| $1.61M | ﹤0.01% |
10,313
+60
| +0.6% | +$9.91K |
|
542
General Motors
GM
$76.8B
| $1.48M | ﹤0.01% |
42,407
-290,730
| -87% | -$9.77M |
|
543
Colgate-Palmolive
CL
$74.4B
| $1.28M | ﹤0.01% |
19,610
+119
| +0.6% | +$8.16K |
|
544
AbbVie
ABBV
$435B
| $1.27M | ﹤0.01% |
20,348
-564,063
| -97% | -$34.4M |
|
|
FRP
545
DELISTED
Fairpoint Communications, Inc.
FRP
| $1.23M | ﹤0.01% |
65,867
| – | – |
|
546
EQT Corp
EQT
$32.3B
| $1.22M | ﹤0.01% |
34,256
+53
| +0.2% | +$1.97K |
|
|
RDS.B
547
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.21M | ﹤0.01% |
20,928
+4,029
| +24% | +$220K |
|
548
GSK
GSK
$106B
| $1.21M | ﹤0.01% |
25,131
+4,839
| +24% | +$239K |
|
549
Omnicom Group
OMC
$23.4B
| $1.21M | ﹤0.01% |
14,171
+504
| +4% | +$42.3K |
|
550
Invesco QQQ Trust
QQQ
$484B
| $1.19M | ﹤0.01% |
+10,023
| New | +$1.18M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2016 Portfolio in Review
As of Q4 2016, Loomis, Sayles & Company held 1,190 positions worth $40.7B, up 3.1% from $39.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Loomis, Sayles & Company's Q4 2016 filing shows 178 new, 257 increased, 455 reduced and 177 closed positions. Its largest new stake was Yum China: 10,852,792 shares worth $283M. The largest sale was Yum! Brands, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q4 2016 buy was Yum China: 10,852,792 shares worth $283M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2016, an estimated $216M increase.
- Loomis, Sayles & Company's biggest Q4 2016 reduction was Yum! Brands, cutting an estimated $128M.
- Loomis, Sayles & Company fully exited Alcoa Inc in Q4 2016, selling an estimated $71.7M.
- Loomis, Sayles & Company's ten largest holdings make up 29% of its $40.7B portfolio in Q4 2016.
- Loomis, Sayles & Company opened 178 new positions and closed 177 in Q4 2016.
- Loomis, Sayles & Company's portfolio value rose 3.1% quarter-over-quarter to $40.7B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2016, filed 14 Feb 2017.